Home / Centerstage / 2014 / may / Week 1 /
Merck & Co Inc. announces its intention to sell its consumer business to Germany's Bayer AG for $14 billion. This strategic move allows Merck to focus on its core pharmaceutical business while providing Bayer with a significant expansion in the consumer health market. The acquisition strengthens Bayer's position in over-the-counter products, vitamins, and other consumer healthcare segments.
Monday, 5 May, 2014